Related references
Note: Only part of the references are listed.The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease
Z. Gan-Or et al.
NEUROGENETICS (2010)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease
Yulia Golub et al.
PARKINSONISM & RELATED DISORDERS (2009)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Z. Gan-Or et al.
NEUROLOGY (2008)
Mutations in LRRK2 as a cause of Parkinson's disease
Benoit I. Giasson et al.
NEUROSIGNALS (2008)
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease -: Is there a gender effect?
A. Orr-Urtreger et al.
NEUROLOGY (2007)
Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation
Judith Miklossy et al.
ACTA NEUROPATHOLOGICA (2007)
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
A. Rajput et al.
NEUROLOGY (2006)
Linkage disequilibrium and association of MAPT H1 in Parkinson disease
L Skipper et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
